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Abstract 
This data article contains data related to the research article entitled ‘Substrate topography: A 
valuable in vitro tool, but a clinical red herring for in vivo tenogenesis’ [1]. We report 
measurements on tenocyte viability, metabolic activity and proliferation on substrates with different 
topographies. We also report the effect of substrates with different topographies on host cells in a 
subcutaneous model. 
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Specifications Table 
Subject area Biology 
More specific subject 
area 
Biomaterials / Tissue Engineering 
Type of data Figures 
How data was acquired In vitro assays; In vivo assays 
Data format Analysed data 
Experimental factors Substrates with various topographies 
Experimental features In vitro and in vivo data 
Data source location Galway, Ireland 
Data accessibility Data are supplied in this article 
  
Value of the data:  
• Two-dimensional substrates, with appropriate topographical features and rigidity, may be 
used to maintain cell phenotype ex vivo. 
• Two-dimensional substrates, with sub-micron to low micron features, may not be suitable 
for directional neotissue formation in vivo. 
• Three-dimensional constructs may be more effective tools for directional neotissue 
formation in vivo. 
 
Data 
Herein, we assessed tenocyte viability, metabolic activity and proliferation on substrates with 
different topographies. The substrates were poly(lactic-co-glycolic acid) (PLGA) based with 
constant groove and line width of 1,911.42 ± 37.50 nm and 2,101.78 ± 35.21 nm respectively and 
variable groove depth of 37.48 ± 3.4 nm, 317.29 ± 7.05 nm and 1,988.2 ± 195.3 nm. Non-imprinted 
substrates were used as control. We also assessed these these substrates in a subcutaneous model. 
 
Experimental Design, Materials and Methods 
Human tenocyte viability, metabolic activity and proliferation 
Live/Dead® assay (BioSource International, Invitrogen, Ireland) was performed on days 1, 5 and 10 
to assess cellular viability, as per manufacturer’s protocol. Briefly, cells were washed 3 times with 
HBSS and exposed to the staining solution of calcein and ethidium homodimer. The cells were 
incubated at 37 °C for 45 min. Following staining, the cells were viewed using the BX51 Olympus 
fluorescence microscope and analysed using ImageJ. 
Cell metabolic activity was determined using alamarBlue® assay on days 1, 5, and 10, as per 
manufacturer’s protocol. Briefly, alamarBlue® dye was diluted with HBSS to make a 10 % (v/v) 
alamarBlue® solution. Media was removed from each well and 0.5 ml alamarBlue® solution was 
added to each well. Cell were incubated for 3 h at 37 °C; the absorbance of the alamarBlue® was 
measured at wavelengths of 550 nm and 595 nm using a micro plate reader (Varioskan Flash, 
Thermo Scientific, UK). The level of metabolic activity was calculated using the simplified method 
of calculating % reduction, according to the supplier’s protocol. 
Cell proliferation was assessed on days 1, 5, and 10, by counting DAPI stained cell nuclei, using the 
BX51 Olympus fluorescence microscope (please see section 2.3 for more details). 
All experiments (viability, metabolic activity and proliferation) were repeated in three independent 
experiments and each experiment was performed in triplicate. 
 
In vivo study and analysis 
The Animal Care Research Ethics Committee of NUI Galway approved all experimental protocols. 
For the subcutaneous study, female Lewis rats (200g – 250g) were used, following a protocol 
described previously [2]. Briefly, surgery was performed on rats under general anaesthesia. 
Incisions were made at the back of each animal, allowing insertion of a 0.5 cm x 0.5 cm structured 
substrate. The wound was then closed, using biodegradable sutures. Following euthanisation, the 
substrates were harvested at days 2 and 14 and were stained using DAPI and rhodamine conjugated 
phalloidin. Three animals were used per time point and at each animal all three structured substrates 
were implanted. Images were captured with an Olympus IX-81 inverted microscope (Olympus 
Corporation, Tokyo, Japan). 
  
Results 
Figure 1: Tenocyte viability, metabolic activity and proliferation as a function of substrate 
topography and time in culture. No significant differences were detected. 
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Figure 2: Microscopic images of host cells on substrates with different topographies. Nuclei were stained blue with DAPI and cytoskeleton 
was stained red with rhodamine-conjugated phalloidin. Substrate topography did not affect host cell orientation. 
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